Hello world!

by admin | Mar 2, 2026 | Uncategorized

Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Next Entries »

Recent Posts

  • Chemical Proteomics in Drug Discovery: Better Target-Engagement Decisions
  • Target Engagement Profiling
  • CellEKT Reaches 100,000th Cell Processing Run
  • Omivera Launches Strategic Partnership Program to Support Emerging Biotech Companies
  • Omivera Expands European Operations with New Innovation Hub in Leiden

Recent Comments

  1. A WordPress Commenter on Hello world!
Whether you’re validating hits, optimizing leads, or working towards translational studies, Omivera helps you generate the biological evidence needed to make confident drug discovery decisions.

Quick Links
Home
Technology
Services
About Us
Contact

Technologies
CellEKT
Activity-Based Protein Profiling
Residue-Specific Proteomics

Inhibitor Profiling Services

Kinase inhibitors
Serine hydrolase inhibitors
Covalent inhibitors

Contact

Omivera B.V.
J.H. Oortweg 21, 2333 CH Leiden, The Netherlands

info@omivera.com

© 2026 Omivera B.V. All rights reserved.

Privacy Policy | Cookie Policy | Terms & Conditions

Stay informed about developments in chemical proteomics, target engagement science, and drug discovery.